An in vivo ovarian cancer study detected a >2-fold increase in the transcriptional expression levels of GABRP in metastatic implants of human ovarian carcinoma xenografts in mice compared to SK-OV-3 ovarian carcinoma cells 104. The gene discussed is GABRP; the disease is ovarian carcinoma.